The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
The Clinical Assessment Interview for Negative Symptoms (CAINS): Final Development and Validation
Open accessAbstract
OBJECTIVE: A major barrier to developing treatments for negative symptoms has been measurement concerns with existing assessment tools. Fulfilling the top recommendation of the National Institute of Mental Health's Consensus Development Conference on Negative Symptoms, the Clinical Assessment Interview for Negative Symptoms (CAINS) was developed using an iterative, empirical approach, and includes items assessing motivation, pleasure, and emotion expression. The authors employed multiple analytic techniques to develop the CAINS and here provide final development and validation results. METHOD: The CAINS structure, interrater agreement, test-retest reliability, and convergent and discriminant validity were assessed in a large and diverse sample of 162 outpatients with schizophrenia or schizoaffective disorder recruited from four sites. RESULTS: Three items with poor psychometric properties were removed, resulting in a 13-item CAINS. The CAINS factor structure was replicated, demonstrating two modestly correlated scales: expression (four items) and motivation/pleasure (nine items). The scales demonstrated good internal consistency, test-retest stability, and interrater agreement. Strong convergent validity was demonstrated by linkages with other negative symptom measures, self-report scales of sociality, pleasure, and motivation, and coded facial expressions. Discriminant validity was shown by independence from depression, medication side effects, and cognition. Notably, the CAINS scales were related to real-world vocational, independent living, and social/familial functioning. CONCLUSIONS: The CAINS is an empirically developed and evaluated measure of negative symptoms. Findings indicate that the CAINS is brief yet comprehensive and employable across a wide range of research and clinical contexts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other forms of disorders, i.e. schizophrenia and bipolar disorder, can be evaluated with screenings such as the Clinical Assessment Interview for Negative Symptoms (CAINS) [60], Brief Negative Symptom Scale (BNSS) [61], the Social Skills Performance Assessment (SSPA) [53], and several others that measure the effects of thought and mood disorders.”
From A Review of Automated Speech and Language Features for Assessment of Cognitive and Thought Disorders (2020) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intraclass correlations: Uses in assessing rater reliability.
Shrout, P. E., & Fleiss, J. L. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.2.420 · Cited by 24,532
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Carver, C. S., & White, T. L. (1994) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.67.2.319 · Cited by 7,306
Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D. S., Quinn, K., Sanislow, C., & Wang, P. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09091379 · Cited by 7,067
A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
Simpson, G. M., B., M., B., G., Angus, J. W. S., P., F. R. C., & M., D. P. (1970) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1970.tb02066.x · Cited by 3,265
Scale for the Assessment of Negative Symptoms (SANS)*
(1989) · The British Journal of Psychiatry · doi:10.1192/s0007125000291502 · Cited by 2,710
Scale for the Assessment of Negative Symptoms
Andreasen, N. C. (1982) · PsycTESTS Dataset · doi:10.1037/t12696-000 · Cited by 1,888
The NIMH-MATRICS Consensus Statement on Negative Symptoms
Kirkpatrick, B., Fenton, W. S., Carpenter, W. T., & Marder, S. R. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj053 · Cited by 1,311
A depression rating scale for schizophrenics
Addington, D. E., Addington, J., & Schıssel, B. (1990) · Schizophrenia Research · doi:10.1016/0920-9964(90)90005-r · Cited by 1,270
Flagged first, then by citations
Research works printed but not linked: 3
- Embretson S, 2000, Psychometric Methods: Item Response Theory for Psychologists
- First MB, 1996, Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition
- Aldenderfer RK, 1985, Cluster Analysis
Cited by
Sorted by citations
Items 501–600 of 726
Grip Strength as a Marker of Resting-State Network Integrity and Well-Being in Early Psychosis
Ward, H. B., Beermann, A., Felix, K. M., Narisetti, L., Lewandowski, K. E., Coleman, M., Sylvain Bouix, A., Holt, D. J., Öngür, D., Breier, A. F., et al. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20240780 · Cited by 7
Savage, C. L. G., Orth, R. D., Bennett, M. E., & Blanchard, J. J. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.07.010 · Cited by 5
Self-citationLui, S. S. Y., Wong, Y.-L., Huang, Y., Chau, B. C. L., Cheung, E. S. L., Wong, C. H. Y., Wong, R. W. K., Leung, S., Lam, J. P. H., & Chan, R. C. K. (2024) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2024.104211 · Cited by 5
Mechanisms and correlates of incentivized response inhibition in schizophrenia and bipolar disorder
Patel, P. K., Green, M. F., Barch, D. M., & Wynn, J. K. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.02.027 · Cited by 6
“…(Ventura et al., 1995) to assess presence and overall severity of psychiatric symptoms (i.e., positive symptoms, negative symptoms, depression, agitation) and the Clinical Assessment Interview for Negative Symptoms (Kring et al., 2013) to assess for expressive and motivational negative symptoms.”
ADVANCES IN THE ASSESSMENT OF THE NEGATIVE SYMPTOMS OF THE PSYCHOTIC SYNDROME
Fonseca‐Pedrero, E., Inchausti, F., Sierra, J. O., Gutiérrez, C., Gooding, D. C., & Paíno, M. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 5
Revisions and refinements of the diagnosis of schizophrenia in DSM‐5.
Reddy, L. F., Horan, W. P., & Green, M. F. (2014) · Clinical Psychology Science and Practice · doi:10.1111/cpsp.12071 · Cited by 5
Self-citationAn Affective Neuroscience Model of Impaired Approach Motivation in Schizophrenia
Strauss, G. P., Whearty, K. M., Frost, K. H., & Carpenter, W. T. (2016) · Nebraska Symposium on Motivation/The Nebraska symposium on motivation · doi:10.1007/978-3-319-30596-7_6 · Cited by 6
Socio-Motor Improvisation in Schizophrenia: A Case-Control Study in a Sample of Stable Patients
Salesse, R. N., Casties, J.-F., Capdevielle, D., & Raffard, S. (2021) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2021.676242 · Cited by 5
Examining racial differences in community integration between black and white homeless veterans
Novacek, D. M., Wynn, J. K., Gabrielian, S. E., Glynn, S. M., Hellemann, G., Horan, W. P., Kern, R. S., Lee, J., Marder, S. R., Sugar, C. A., et al. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2021.114385 · Cited by 8
Self-citationLui, S. S. Y., Wang, L., Lau, W. Y. S., Shing, E., Yeung, H. K. H., Tsang, K. C. M., Zhan, N., Cheung, E. S. L., Ho, K. K. Y., Hung, K. S. Y., et al. (2023) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2023.103467 · Cited by 5
Ihler, H. M., Lyngstad, S. H., Gardsjord, E. S., Widing, L. H., Flaaten, C. B., Åsbø, G., Wold, K. F., Engen, M. J., Simonsen, C., Ueland, T., et al. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.01.024 · Cited by 7
Symptômes négatifs : clinique et psychométrie
Adida, M., Azorin, J., Belzeaux-R, R., & Fakra, É. (2015) · L Encéphale · doi:10.1016/s0013-7006(16)30004-5 · Cited by 5
“[6] Kring AM, Gur RE, blanchard JJ, Horan WP, Reise SP.”
BackgroundNegative symptoms in treatment-resistant schizophrenia and its relationship with functioning
Lui, S. S. Y., Lam, E. H., Wang, L., Leung, P. B. M., Cheung, E. S. L., Wong, C. H. Y., Zhan, N., Wong, R. W. K., Siu, B. W. M., Tang, D. Y. Y., et al. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.07.008 · Cited by 4
Niederlohmann, E. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1717734 · Cited by 4
“The strongest empirical components are the existing measurement and documentation tools (BNSS/CAINS for negative symptoms, Mini-ICF-APP for functioning, and COPEDS for CPD screening) and the medication effects literature (5, 6, 18, 20 – 25).”
Cernvall, M., Bengtsson, J., & Bodén, R. (2024) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2024.2324060 · Cited by 4
Dewan, M., (Daniels), E. C., Hunt, J. E., Bryant, E. K. R., Trikeriotis, S. I., Kelly, D. L., Adams, H. A., Hare, S., & Waltz, J. A. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.09.026 · Cited by 4
Evaluación psicopatológica del lenguaje en las esquizofrenias: revisión bibliográfica
Bulnes, N. J. (2019) · Revista chilena de neuro-psiquiatría · doi:10.4067/s0717-92272019000100034 · Cited by 4
Reavis, E. A., Wynn, J. K., & Green, M. F. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.08.020 · Cited by 4
Larsen, E. M., Donaldson, K. R., Jonas, K. G., Lian, W., Bromet, E. J., Kotov, R., & Mohanty, A. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.08.011 · Cited by 3
Turning the Spotlight on Apathy: Identification and Treatment in Schizophrenia Spectrum Disorders
Lyngstad, S. H., Lyne, J., Ihler, H. M., van der Meer, L., Færden, A., & Melle, I. S. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbad070 · Cited by 4
Luther, L., Jarvis, S. A., Spilka, M. J., & Strauss, G. P. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01714-7 · Cited by 6
“…measure primary as opposed to secondary negative symptoms (i.e., negative symptoms due to depression or positive symptoms) as well as more contemporary negative symptom measures like the Brief Negative Symptom Scale (BNSS; [34]) and Clinical Assessment Interview for Negative Symptoms (CAINS; [35]).”
Bradley, E., Portanova, J., Woolley, J. D., Buck, B., Painter, I. S., Hankin, M., Xu, W., & Cohen, T. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115893 · Cited by 5
Fang, J., Cai, R., Hu, Y., Wang, Y., Ling, Y., Lv, Y., Fang, X., Zhang, X., & Zhou, C. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.07.006 · Cited by 4
Dysfunctional Alpha Modulation as a Mechanism of Working Memory Impairment in Serious Mental Illness
Erickson, M. A., Boudewyn, M. A., Winsler, K., Li, C., Barch, D. M., Carter, C. S., Frank, M. J., Gold, J. M., MacDonald, A. W., Ragland, J. D., et al. (2024) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2024.07.022 · Cited by 4
Andersen, E., Campbell, A., Girdler, S. S., Duffy, K. A., & Belger, A. (2018) · Clinical Neurophysiology · doi:10.1016/j.clinph.2018.10.019 · Cited by 6
“, 1992) was administered to patients to evaluate positive, negative, and general symptom subscales, and the Clinical Assessment Interview for Negative Symptoms (CAINS; Kring et al., 2013) was administered to all participants to assess negative symptoms (e.”
MethodCluster A Personality Disorders
Kerns, J. G. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108333931.037 · Cited by 4
Ab, S., Иванов, С. В., Yakhin, K. K., Voronova, E. I., Kharkova, G. S., Skurygina, E. I., Konohova, M. V., Beybalaeva, T. Z., & Katok, A. A. (2020) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202012012167 · Cited by 4
Validity and reliability of a Persian version of the self- evaluation of negative symptoms (SNS)
Mazhari, S., Karamooz, A., Shahrbabaki, M. E., Jahanbakhsh, F., & Dollfus, S. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03521-7 · Cited by 4
“In recent studies, different standardized tools such as Brief Negative Symptom Scale (BNSS) and Clinical Assessment Interview for Negative Symptoms (CAINS) have been presented for a more effective treatment of negative symptoms [5, 6].”
MethodDefining negative symptoms remission in schizophrenia using the Brief Negative Symptom Scale
Rekhi, G., Ang, M. S., Chan, Y. H., Fernández-Egea, E., Kirkpatrick, B. W., & Lee, J. (2022) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2022.01.007 · Cited by 4
Kaizerman-Dinerman, A., Roe, D., Demeter, N., & Josman, N. (2023) · BMC Psychiatry · doi:10.1186/s12888-022-04510-0 · Cited by 4
Bengtsson, J., Olsson, E. M. G., Persson, J., & Bodén, R. (2023) · Upsala Journal of Medical Sciences · doi:10.48101/ujms.v128.8949 · Cited by 4
“HRV: heart rate variability; iTBS: intermittent theta burst stimulation; SDNN: standard deviation of the RR interval; CAINS: Clinical Assessment Interview for Negative Symptoms; MADRS-S: Montgomery Asberg Depression Rating Scale self-rating; BPRS: Brief Psychiatric Rating Scale; EQ-VAS: EuroQoL Group Visual Analogue S…”
BackgroundInfluentialAssessment Tools in Psychiatry
Demyttenaere, K., & Heirman, E. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_101-1 · Cited by 4
Cella, M., Tomlin, P., Robotham, D., Green, P. A., Griffiths, H., Stahl, D. R., & Valmaggia, L. (2023) · Efficacy and Mechanism Evaluation · doi:10.3310/hnvc2041 · Cited by 5
Range adaptation in schizophrenia: A one-year longitudinal study
Wang, L., Gong, J., Huang, Y., Shi, S.-H., Yan, C., Hu, H., Wang, Y., Lui, S. S. Y., Ju, K., & Chan, R. C. K. (2023) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2023.100297 · Cited by 4
Riehle, M., Brauer, S., Lincoln, T. M., & Pruessner, L. (2024) · Cognitive Therapy and Research · doi:10.1007/s10608-024-10525-6 · Cited by 4
“These are the gold standard, particularly for negative symptoms, both in people at risk for psychosis (Strauss et al., 2020) and in people with schizophrenia (Kirkpatrick et al., 2010; Kring et al., 2013).”
Validation of the Korean Version of the Clinical Assessment Interview for Negative Symptoms
Jang, S.-K., Park, S., Choi, K., Yi, J.-S., Park, J.-K., Lee, J. S., & Lee, S. (2017) · Psychiatry Investigation · doi:10.4306/pi.2017.14.4.413 · Cited by 4
Ayoub, I. A., Andrade, J. C., Serpa, M. H., Alves, T. M., Hortêncio, L., Freitas, E. L., van de Bilt, M. T., Wulf Rössler, A., Gattaz, W. F., & Loch, A. A. (2020) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001237 · Cited by 4
“Other studies that tried to correlate the sphere of blunted affect with functional deficits were inconclusive, with some indicating a relationship (Kring et al., 2013) and others not (Foussias et al., 2009; Green et al., 2012).”
BackgroundAnhedonia in Schizophrenia: A Brief History and Overview of the Construct
Buck, B., & Lysaker, P. H. (2014) · Springer eBooks · doi:10.1007/978-94-017-8610-2_1 · Cited by 4
Measuring negative symptom change in schizophrenia: considering alternatives to self-report
Gupta, M., Holshausen, K., Gou, L. H., & Bowie, C. R. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.935341 · Cited by 8
“There is thus a nonlinear SANS Objectively scored 25% Other report 14%Self-report 30% Self-report 69% Clinical impression 45% Clinical impression 86% Clinical impression 31% PANSS CAINS Figure 1.”
MethodInfluentialManagement of primary negative symptoms in schizophrenia: an one-year observational study.
Franza, F., Fasano, V., Guglielmo, S. D., & Solomita, B. (2015) · PubMed · Cited by 4
The Impact of Metacognition on the Development and Maintenance of Negative Symptoms
McLeod, H. J., Gumley, A. I., & Schwannauer, M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405172-0.00007-7 · Cited by 4
Amendment of traditional assessment measures for the negative symptoms of schizophrenia
Farreny, A., Usall, J., Cuevas‐Esteban, J., Ochoa, S., & Brébion, G. (2018) · European Psychiatry · doi:10.1016/j.eurpsy.2017.11.003 · Cited by 5
“These are the Clinical Assessment Interview for Negative Symptoms (CAINS) [42,43] and the Brief Negative Symptom Scale (BNSS) [44,45].”
MethodGold, J. M., Bansal, S., Gaspar, J. M., Chen, S., Robinson, B. M., Hahn, B., & Luck, S. J. (2019) · Psychological Medicine · doi:10.1017/s0033291719000862 · Cited by 4
“We administered the Brief Psychiatric Rating Scale (BPRS, Overall and Gorham, 1962) to quantify symptom severity, the Clinical Assessment Interview for Negative Symptoms (Kring et al., 2013) to quantify negative symptoms, the Specific Levels of Function informant report (SLOF) to measure level of community function (S…”
Methodde Medeiros, H. L. V., da Silva, A. M. P., Roudig, R. M. E. W., de Souza, S. L., Sougey, É. B., Vasconcelos, S. C., & Lima, M. D. D. C. (2019) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/0101-60830000000211 · Cited by 4
Validation of the Turkish version of the self-evaluation of negative symptoms scale (SNS)
Polat, I., İnce, E., Elmas, S., Karakaş, S., Aydemır, Ö., & Üçok, A. (2022) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2022.2082985 · Cited by 4
“The Brief Negative Symptoms Scale (BNSS) (Kirkpatrick et al., 2011) and the Clinical Assessment Interview for Negative Symptoms (CAINS) (Kring et al., 2013) were created to meet this need and are now widely used internationally.”
MethodFinding a Medication for Negative Symptoms in Schizophrenia: Why So Many Failures?
Marder, S. R. (2026) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20251316 · Cited by 4
Wynn, J. K., & Green, M. F. (2024) · Clinical EEG and Neuroscience · doi:10.1177/15500594241252897 · Cited by 3
The Impact of Childhood Trauma on the Negative Symptoms of Schizophrenia
Ware, K., Misiak, B., Hamza, E. A., Nalla, S., & Moustafa, A. A. (2024) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001788 · Cited by 7
Leathem, L. D., Barch, D. M., Moran, E. K., Patel, P. K., Green, M. F., & Wynn, J. K. (2025) · Psychiatry Research · doi:10.1016/j.psychres.2025.116629 · Cited by 3
“Trained clinical interviewers rated motivational deficits with the Clinical Assessment Interview for Negative Symptoms (CAINS; (Kring et al., 2013)) Motivation and Pleasure (MAP) scale.”
Treatment trials for negative symptoms in schizophrenia
Glenthøj, L. B., Nielsen, M. Ø., & Nordentoft, M. (2025) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000001067 · Cited by 3
Dwyer, K., Bennett, M. E., & Blanchard, J. J. (2020) · Journal of Psychopathology and Behavioral Assessment · doi:10.1007/s10862-020-09818-3 · Cited by 3
Self-citationCatalano, L. T., Wynn, J. K., Eisenberger, N. I., Horan, W. P., Lee, J., McCleery, A., Miklowitz, D. J., Reavis, E. A., Reddy, L. F., & Green, M. F. (2024) · Clinical EEG and Neuroscience · doi:10.1177/15500594231222979 · Cited by 5
“41,42”
Self-citationThörnblom, E., Steinholtz, L., Persson, J., Axelson, H. W., & Bodén, R. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.11.055 · Cited by 3
“To examine the relationship between baseline TMS indices and clinical effect of iTBS, clinical effect was defined as reduction in the total score on The Clinical Assessment Interview for Negative Symptoms (CAINS) (Kring et al., 2013).”
InfluentialGao, Z., Xiao, Y., Zhu, F., Bo, T., Zhao, Q., Yu, W., Bishop, J. R., Gong, Q., & Lui, S. (2025) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13782 · Cited by 3
“The recently developed scales including the Brief Negative Symptom Scale (BNSS) 66 and Clinical Assessment Interview for Negative Symptoms (CAINS), 67 may capture more symptom variance and provide better assessment for speci fi c symptom subdomains.”
Berretta, S. A., Abaya, N. M., Parrish, E. M., McBride, L. E., Moore, R. C., Ackerman, R. A., Harvey, P. D., Pinkham, A. E., & Depp, C. A. (2025) · NPP—Digital Psychiatry and Neuroscience · doi:10.1038/s44277-024-00024-7 · Cited by 3
Marotti, J., Saunders, R., Montague, A. E., & Fornells‐Ambrojo, M. (2025) · Psychological Medicine · doi:10.1017/s003329172500008x · Cited by 3
Evidence for shallow cognitive maps in schizophrenia
Karagoz, A. B., Moran, E. K., Barch, D. M., Kool, W., & Reagh, Z. M. (2025) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-025-01283-3 · Cited by 5
“Clinician-rated negative symptoms were assessed in all patient groups by using the Clinical Assessment Interview for Negative Symptoms (CAINS) (Kring et al., 2013), which includes a Motivation and Pleasure (MAP) and Expression (EXP) subscale.”
Emotional mimicry and smiling behaviors in schizophrenia: An ecological approach
Parisi, M., Raffard, S., Fauviaux, T., Vattier, V., Mrabet, D., Capdevielle, D., & Marín, L. (2025) · Schizophrenia · doi:10.1038/s41537-025-00632-y · Cited by 3
van Gool, R., Cay, M., van der Heijden, H. C., Golden, E., Cao, A., Ren, B., Gonzalez–Heydrich, J., Shinn, A. K., & Upadhyay, J. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.0039-25.2025 · Cited by 3
Animal Models of Psychotic Disorders
Kirby, B. P. (2015) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-800981-9.00005-5 · Cited by 3
Goldstein, G., Allen, D. N., & DeLuca, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-802203-0.00001-8 · Cited by 3
Kulenović, A. D., Mešević, E. S., Ribić, E., Repišti, S., Radojičić, T., & Jovanović, N. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02435-8 · Cited by 3
“1 3 factors, which are consistent with the results of previously published studies (Kring et al. 2013; Engel et al. 2014; Chan et al. 2015; Valiente-Gomez et al. 2015; Jung et al. 2016; Rekhi et al. 2019).”
BackgroundMethodResultInfluentialSafont, G., Garriga, M., Amoretti, S., Cuesta, M. J., Parellada, M., González-Pinto, A. M., Bergé, D., Rodríguez–Jiménez, R., Roldán, A., Sarró, S., et al. (2022) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2022.03.002 · Cited by 3
Marić, N. P., Petrović, S. A., Russo, M., Jerotić, S., Ristić, I., Savić, B., Pemovska, T., Milutinović, M., Ribić, E., Markovska-Simoska, S., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.796719 · Cited by 3
“Symptom severity at the time of the evaluation was measured using the 24-item Brief Psychiatric Rating Scale (BPRS) (17) and the 13-item interview-based questionnaire Clinical Assessment Interview for Negative Symptoms (CAINS) (18).”
MethodRiedel, P., Lee, J., Watson, C. G., Jimenez, A. M., Reavis, E. A., & Green, M. F. (2022) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2022.111556 · Cited by 4
Validation of the Social Effort and Conscientious Scale (SEACS) in Schizophrenia
Botello, R. M., Gill, K., Mow, J. L., Leung, L., Mote, J., Mueser, K. T., Gard, D. E., & Fulford, D. (2023) · Journal of Psychopathology and Behavioral Assessment · doi:10.1007/s10862-023-10031-1 · Cited by 3
“…such as the Scale for the Assessment of Negative Symp - toms (SANS; Andreasen, 1989) or the Clinical Assessment Interview for Negative Symptoms (CAINS; Kring et al., 2013 ), conflate reduced social interest and pleasure with the behavioral outputs of such impairment (Marder & Galderisi, 2017 ).”
BackgroundSamochowiec, J., Jabłoński, M., Plichta, P., Piotrowski, P., Stańczykiewicz, B., Bielawski, T., & Misiak, B. (2023) · Psychopathology · doi:10.1159/000529244 · Cited by 3
“Similar findings were obtained by Dollfus et al. [12] and other studies that used different tools to record negative symptoms [31, 32].”
ResultWynn, J. K., Clayson, P. E., Green, M. F., Jimenez, A. M., Lee, J., Reavis, E. A., & Horan, W. P. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.16034 · Cited by 3
“…2008) from the Brief Psychiatric Rating Scale (BPRS) (Ventura et al., 1993) and negative symptoms were assessed with the two subscales from the Clinical Assessment Interview for Negative Symptoms (CAINS) (Kring et al., 2013): motivation and pleasure (MAP) and expressive negative symptoms (EXP).”
MethodInfluentialSelf-citationBengtsson, J., Rad, P., Cernvall, M., & Bodén, R. (2023) · Annals of General Psychiatry · doi:10.1186/s12991-023-00474-x · Cited by 4
“Our main result indicated that the inter-rater agreement was acceptable, which is in accordance with previous studies in schizophrenia [17].”
BackgroundMethodResultInfluentialLe, T. P., Green, M. F., Wynn, J. K., Iglesias, J., Franco, R., Kopelowicz, A. J., & Kern, R. S. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.11.003 · Cited by 3
Dark, F. L., Galloway, G. J., Gray, M. A., Cella, M., Monte, V. E. D., Gore‐Jones, V., & Ritchie, G. (2024) · JMIR Research Protocols · doi:10.2196/52505 · Cited by 4
“The Clinical Assessment Interview for Negative Symptoms (CAINS) is a measure of anhedonia, avolition, and emotional expression [40] with strong psychometric properties [41].”
MethodAnhedonia and Negative Symptom Schizotypy
Kwapil, T. R., Gross, G. M., Chun, C. A., Silvia, P. J., & Neus Barrantes-vidal, A. (2014) · Springer eBooks · doi:10.1007/978-94-017-8610-2_9 · Cited by 3
Assessing Psychosis in African American Clients
Culbreth, A. J., & Strauss, G. P. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1004-5_16 · Cited by 3
Assessing Social Affiliative Behavior: A Comparison of in Vivo and Video Tasks
Garcia, C. P., Catalano, L. T., Dwyer, K., McCarthy, J. M., Bennett, M. E., & Blanchard, J. J. (2018) · Behavior Therapy · doi:10.1016/j.beth.2018.03.006 · Cited by 4
Self-citationAssanovich, M. V. (2020) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2020-1-83-92 · Cited by 3
“матики: NSA-4 (Методике 4-пунктовой оценки негативных симптомов), BNSS (Краткой шкале негативных симптомов) и CAINS (Интервью для клинической оценки негативных симптомов) [5, 13, 14].”
We need to make progress on blunted affect: A commentary
Cowan, T., Phalen, P. L., Brown, C. H., Blanchard, J. J., & Bennett, M. E. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.01.001 · Cited by 2
Self-citationEmotion anticipation and processing in depression: Behavioral, neural, and physiological reactivity
Wlad, M., Struckmann, W., Persson, J., Rosén, J., Fällmar, D., Bodén, R., & Gingnell, M. (2025) · European Psychiatry · doi:10.1192/j.eurpsy.2025.10043 · Cited by 2
“Symptoms of anhedonia were assessed using the Clinical Inter-view for Assessment of Negative Symptoms (CAINS) [27], which discriminates between consummatory and anticipatory pleasures [28, 29].”
Assessment of motivation in schizophrenia: Patient- and clinician-rated outcomes
Fernández-Egea, E., Robert, G., Mané, A., Sabé, M., Kuenzi, N., Kaliuzhna, M., Carruzzo, F., Diniel, F., Riclet, A. J., Martínez-Sadurní, L., et al. (2025) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.sjpmh.2025.08.001 · Cited by 2
Why clinical neuropsychology matters in schizophrenia care
Øie, M. G., Barbosa, F., Lettner, S., Baker, G. A., Duarte, C., Hessen, E., & Ueland, T. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1713751 · Cited by 3
“…Positive and Negative Syndrome Scale (PANSS) (Kay et al., 1987), the Scale for the Assessment of Negative Symptoms (SANS) (Andreasen, 1981), the Brief Negative Symptom Scale (BNSS) (Kirkpatrick et al., 2011), and the Clinical Assessment Interview for Negative Symptoms (CAINS) (Kring et al., 2013).”
Saperia, S., Prosserman, A., Anaya, E. F., Agarwal, S. M., Hahn, M., Best, M. W., Kidd, S. A., Zakzanis, K. K., & Foussias, G. (2025) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaf229 · Cited by 2
Luther, L., Cooper, J. A., Treadway, M. T., Knippenberg, A. R., Walker, E. F., Gold, J. M., Waltz, J. A., Schiffman, J. E., Ellman, L. M., Mittal, V. A., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03474-x · Cited by 3
“The fi ve negative symptom domains [48] were measured either with the Brief Negative Symptom Scale (BNSS [49]), Clinical Assessment Interview for Negative Symptoms (CAINS [50]), Scale for the Assessment of Negative Symptoms (SANS [51]), or Negative Symptom Inventory-Psychosis Risk (NSI-PR [52]).”
Beyond the emotion paradox: Avenues to understanding anhedonia in schizophrenia
Pillny, M., Edwards, C. J., & Riehle, M. (2026) · Schizophrenia Research · doi:10.1016/j.schres.2026.04.003 · Cited by 2
Yang, Q. Y., Wu, H. Q., Zhu, Z. H., Yin, X. Y., Hou, W. L., Man, L. J., Bian, W., Wang, H. Y., Zhang, H., Yu, X., et al. (2026) · Schizophrenia Research · doi:10.1016/j.schres.2026.04.021 · Cited by 2
Lui, S. S. Y., Chan, J. W. S., Chan, J. L. F., Lam, K. H. Y., Choi, L.-Y., Wong, R. W. K., Leung, P. B. M., Zhan, N., Wong, J. W. Y., Chiu, M. W. Y., et al. (2026) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.70094 · Cited by 2
“Nevertheless, the CAINS-MAP and CAIN-EXP did not appear to in fl uence other SID performance variables, including anticipatory pleasure and consummatory pleasure in TRS and remitted schizophrenia patients.”
InfluentialStructured Diagnostic Interview Schedules
Gerritsen, C. J. (2021) · Comprehensive Clinical Psychology · doi:10.1016/b978-0-12-818697-8.00112-6 · Cited by 2
The Role of Disability Benefits as an Environmental Factor Contributing to Negative Symptoms
Collins, D. E., Luther, L., Raugh, I. M., Condray, R., Allen, D. N., & Strauss, G. P. (2022) · Schizophrenia Bulletin · doi:10.1093/schbul/sbac077 · Cited by 2
Negative symptoms in drug-naive patients with a first-episode psychosis (FEP)
Cuñat, O., Hoyo, B., Vila‐Badia, R., Serra‐Arumí, C., Butjosa, A., Cacho, N. D., Colomer-Salvans, A., Dolz, M., Cuevas‐Esteban, J., Iglesias-González, M., et al. (2023) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2023.103448 · Cited by 2
Dalloul, N., Moran, E. K., Gold, J. M., Carter, C. S., MacDonald, A. W., Ragland, J. D., Silverstein, S. M., Luck, S. J., & Barch, D. M. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbad095 · Cited by 2
Reavis, E. A., Wynn, J. K., & Green, M. F. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.08.016 · Cited by 2
“…and medical history, the updated version of the Structured Clinical Interview for DSM-5 (SCID-1) (First et al., 2015), the Expanded Brief Psychiatric Rating Scale (BPRS) (Overall and Gorham, 1962), and the Clinical Assessment Interview for Negative Symptoms (CAINS) (Kring et al., 2013).”
Delay, C., Link, P. C., Holden, J. L., & Granholm, E. L. (2025) · Schizophrenia Research · doi:10.1016/j.schres.2025.01.014 · Cited by 2
French Validation of the Brief Negative Symptom Scale (BNSS)
Métivier, L., Tréhout, M., Leroux, E., Rothärmel, M., & Dollfus, S. (2025) · The Canadian Journal of Psychiatry · doi:10.1177/07067437251328350 · Cited by 2
Associations between negative symptoms and thermal pain perception in bipolar I disorder
Vrolix, L., Legarreta, J. H., van der Heijden, H. C., van Gool, R., Ray, A., Golden, E., Cay, M., Yogesh Rathi, A., Gonzalez–Heydrich, J., O’Donnell, L. J., et al. (2025) · International Journal of Bipolar Disorders · doi:10.1186/s40345-025-00403-9 · Cited by 2
Tomlinson, M. F., & Wright, J. D. (2018) · Journal of Cognitive Psychotherapy · doi:10.1891/0889-8391.32.3.203 · Cited by 2
Lyngstad, S. H., Bettella, F., Aminoff, S. R., Athanasiu, L., Andreassen, O. A., Færden, A., & Melle, I. S. (2020) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13167 · Cited by 2
“Commonly used assessments of negative symptoms, such as the Scale for the Assessment of Negative Symptoms (18), the Clinical Assessment Interview for Negative Symptoms (19), and the Positive and Negative Syndrome Scale (20), are based on observations of behaviors, without links to biological underpinnings and thus wit…”
MethodLe déficit motivationnel dans la schizophrénie
Dollfus, S. (2018) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)30345-0 · Cited by 2
Uka, F., Repišti, S., Arënliu, A., Ramadani, F., Bërxulli, D., Konjufca, J., & Jovanović, N. (2020) · GLOBAL PSYCHIATRY ARCHIVES · doi:10.2478/gp-2020-0013 · Cited by 2
“…compared with other instruments that measure the same construct, CAINS was shown to have good convergent validity: both CAINS scales were correlated with the negative symptom subscale of Brief Symptom Rating Scale (BPRS; Overall & Gorham, 1962) and with the subscales of SANS (Kring et al., 2013).”
MethodResultInfluentialMaslita, V. Q., Saraswati, P., & Hijrianti, U. R. (2021) · Cognicia · doi:10.22219/cognicia.v9i2.18023 · Cited by 10
Russo, M., Jovanović, N., Uka, F., Konjufca, J., Bërxulli, D., & Arënliu, A. (2022) · GLOBAL PSYCHIATRY ARCHIVES · doi:10.52095/gp.2022.4548.1043 · Cited by 2
Kang, M. S., Wolf, D. H., Kazinka, R., Lee, S., Ruparel, K., Elliott, M. A., Xu, A., Cieslak, M., Prettyman, G., Satterthwaite, T. D., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.01.407197 · Cited by 2
Garbisson, A., Laraki, Y., Dubois, T., André, M., Rainteau, N., Capdevielle, D., & Raffard, S. (2021) · Research Square · doi:10.21203/rs.3.rs-561341/v1 · Cited by 2
Metadata
- Authors
- Kring, A. M., Gur, R. E., Blanchard, J. J., Horan, W. P., & Reise, S. P.
- Affiliations
- University of California, Los Angeles (US)
- Venue
- American Journal of Psychiatry
- Published
- 2013-02
- Volume
- 170
- Issue
- 2
- Pages
- 165-172
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- PMC
- PMC3785242
- OpenAlex
- W2131925003
- Cited by
- 726
- References
- 43
- Citations by year
- 2026: 55 · 2025: 55 · 2024: 51 · 2023: 62 · 2022: 62 · 2021: 48 · 2020: 70 · 2019: 51 · 2018: 61 · 2017: 46 · 2016: 52 · 2015: 51 · 2014: 37 · 2013: 24
- FWCI
- 38.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5r01mh082782-03, 5r01mh082890-03)
- National Institute of Mental Health (1R01MH082890, R01-MH082890, R01-MH082782, R01MH082839, R01MH082783, 1R01MH082782)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- negative symptoms, schizophrenia, schizoaffective disorder, motivation, pleasure, emotional expression, interview assessment, psychometric validation, factor structure, convergent validity, discriminant validity, vocational functioning, independent living, social functioning
- MeSH terms
- Adult, Female, Humans, Interview, Psychological, Male, Middle Aged, Motivation, Outpatients, Psychiatric Status Rating Scales, Psychological Tests, Psychotic Disorders, Schizophrenia, Schizophrenic Psychology, Social Behavior, Socioeconomic Factors, Volition, Reproducibility of Results, Expressed Emotion, Diagnostic and Statistical Manual of Mental Disorders, Pleasure, Anhedonia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review